CRISPR Works and the Price Tag Proves It
Casgevy works. Fifty patients treated globally, $2.2 million per dose, 136 trials running. CRISPR has cleared the highest bar in medicine, and the access problem it created is now the harder engineering challenge.
By Vera Santos · 5 min read